Department of haemato-oncology, Military Cancer Center, Jordanian Royal Medical Services, Amman, Jordan.
World Journal of Biology Pharmacy and Health Sciences, 2025, 21(02), 419-423
Article DOI: 10.30574/wjbphs.2025.21.2.0198
Received on 07 January 2025; revised on 15 February 2025; accepted on 18 February 2025
Spontaneous splenic rupture is an exceedingly rare condition, with no documented cases occurring in patients with myelodysplastic syndromes (MDS). In this case study, we have reported a patient with low-risk MDS who was treated primarily with Epoetin Alpha subcutaneous injections to manage his Anemia for nearly one year and was subsequently diagnosed with spontaneous splenic rupture in our department, which was treated with urgent splenectomy.
Although spontaneous splenic rupture is rare and infrequently reported, further investigations and data collection are necessary to confirm whether certain drugs can lead to serious complications like spontaneous splenic rupture.
Epoetin; Myelodysplastic; Spontaneous; Splenic; Rupture
Preview Article PDF
Muna Hamza Al -khawaldeh, Mohammad Subhi Al-Saudi, Hashem Sami Alnajdawi, Laith Karim Lutfi, Aasem Abdelra’uof Rawshdeh and Majdi Hasan Aljedayeh. Effects of epoetin alpha subcutaneous injections on MDS patient (Case Report). World Journal of Biology Pharmacy and Health Sciences, 2025, 21(02), 419-423. Article DOI: https://doi.org/10.30574/wjbphs.2025.21.2.0198.
Copyright © 2025 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0